Study Stopped
Difficulties with recruitment
Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans
CoINTEGRATE
A Pilot Randomized Controlled Trial of a Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) (CoINTEGRATE- for Foreign-Born Arab Americans- a Dyadic Approach)
1 other identifier
interventional
1
1 country
1
Brief Summary
The purpose of this pilot study is to evaluate the feasibility of a cognitive and affective intervention for foreign born Arab American dyads consisting of the person with Mild Cognitive Impairment (MCI) and participants caregiver. This study will evaluate the feasibility of a cognitive and affective intervention combining Cognitive Behavioral Therapy (CBT), Cognitive Rehabilitation Therapy (CRT), and modifiable lifestyle factors to address the cognitive and affective dysfunctions associated with Mild Cognitive Impairment (MCI) or those with cognitive complaints. The study team hypothesizes that combining evidence-based cognitive and affective therapies (CRT+CBT) with lifestyle modifications is feasible and will improve the cognitive performance and Quality of Life (QoL) in patients with MCI and participants caregivers compared to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2023
CompletedStudy Start
First participant enrolled
May 3, 2023
CompletedFirst Posted
Study publicly available on registry
May 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2024
CompletedDecember 13, 2024
December 1, 2024
1.6 years
May 2, 2023
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of patients that complete the study
week 8 (end of treatment)
Average number of sessions completed
week 8 (end of treatment)
Overall experience based qualitative semi-structured interview
This interview will be conducted at the end of the study and in the order of exit of participants to gather feedback about their satisfaction with the study. This brief interview consists of 3 questions that ask the participants to describe the aspects of the intervention participants found beneficial, willingness to participate again, and whether it was appropriate for participants needs. In addition, a brief quantitative satisfaction survey to rate overall satisfaction, how likely it would be recommend to others, and how satisfied participants are with telemedicine as a mode of delivery.
Week 9 (after treatment ended)
Secondary Outcomes (6)
The Short Form Health Survey (SF-36)
Week 9 (after treatment ended)
The Symbol Digit Modalities Test Score (SDMT-5 minutes)
Week 9 (after treatment ended)
Brief Visuospatial Memory test (BVMT-R-25 minutes)
Week 9 (after treatment ended)
California Verbal Learning Test-Third Edition (CVLT-3-60 minutes)
Week 9 (after treatment ended)
The Memory Complaint Scale (MCS-2 minute) score
Week 9 (after treatment ended)
- +1 more secondary outcomes
Study Arms (2)
CRT plus CBT and Lifestyle modifications
EXPERIMENTALUsual care Psychoeducation
ACTIVE COMPARATORInterventions
Participants will complete an 8-week intervention, 2 sessions per week. Co-INTEGRATE sessions take 30-50 minutes to complete. Weekly on the day of the last therapy session, before or after the session, all patients, regardless of the group assigned to, will be asked to complete an electronic brief questionnaire to provide information, on sleep, recreational habits, alcohol intake, exercise, and smoking.
Participants will complete an 8-week intervention, 2 sessions per week. Co-INTEGRATE sessions take 30-50 minutes to complete. Weekly on the day of the last therapy session, before or after the session, all patients, regardless of the group assigned to, will be asked to complete an electronic brief questionnaire to provide information, on sleep, recreational habits, alcohol intake, exercise, and smoking.
The therapy sessions are coupled with homework and requires some lifestyle modifications for the persons with MCI, such lifestyle adjustments are using a calendar, a diary, maintaining a sleep schedule and exercise.
Participants will receive 15-minute psychoeducation session twice per week for 8 weeks. All research-related sessions will be web-based (on Zoom) and recorded (with approval). Weekly on the day of the last therapy session, before or after the session, all patients, regardless of the group assigned to, will be asked to complete an electronic brief questionnaire to provide information, on sleep, recreational habits, alcohol intake, exercise, and smoking.
Eligibility Criteria
You may qualify if:
- All patients diagnosed with MCI or Persons with Montreal Cognitive Assessment (MoCA) less or equal to 25
- Disease duration less or equal to 3 years
- Age older than 60 years
- Foreign-Born Arab origins, Language: Arabic or English
- Cognitive impairment ≥ 1.0 standard deviation below the test score normed for age and education in at least 2 cognitive domains (verbal learning and memory, processing speed, or visuospatial memory)
- Participants who can provide consent or legally authorized representative who can provide consent on their behalf
- Identified by the patients as the person that provides the most care for them with regards to medical care; may be a spouse, an adult child, a sibling, a relative, or family friend
- Above the age of 18 years Fluent in Arabic and/or English
- Can complete a self-report questionnaire by interview or self-report.
You may not qualify if:
- History of traumatic brain injury (TBI)
- Diagnosed with Covid-19
- Patients with other neurosensory or neurodegenerative diseases
- Younger than 60 years
- Psychiatric disorders other than mild to moderate anxiety and depression
- Diagnosed sleep disorders
- Visual or auditory impairment
- Current or history of alcohol or substance abuse/dependence
- Patients with severe depression or suicidal (ideation or plan) will be instructed to seek mental health, provided with resources, and referred to their primary care provider
- \- Paid caregivers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hala Darwish, PhD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Only the data collectors in this study will be blind to the dyad's allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Nursing
Study Record Dates
First Submitted
May 2, 2023
First Posted
May 11, 2023
Study Start
May 3, 2023
Primary Completion
December 9, 2024
Study Completion
December 9, 2024
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share